Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 4, Issue 5, Pages 625-650
Publisher
Future Science, LTD
Online
2012-03-29
DOI
10.4155/fmc.12.10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral Efficacy upon Administration of a HepDirect Prodrug of 2′-C-Methylcytidine to Hepatitis C Virus-Infected Chimpanzees
- (2011) Steven S. Carroll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- INX-08189, a Phosphoramidate Prodrug of 6-O-Methyl-2′-C-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties
- (2011) John H. Vernachio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity and the metabolic activation pathway of the potent and selective hepatitis C virus pronucleotide inhibitor PSI-353661
- (2011) Phillip A. Furman et al. ANTIVIRAL RESEARCH
- Dual pro-drugs of 2′-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus
- (2011) Christopher McGuigan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
- (2011) B. L. Pearlman et al. CLINICAL INFECTIOUS DISEASES
- Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy Subjects
- (2010) Xiao-Jian Zhou et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- (2010) Drew R Bobeck et al. ANTIVIRAL THERAPY
- 2′-Deoxy-2′-α-fluoro-2′-β-C-methyl 3′,5′-cyclic phosphate nucleotide prodrug analogs as inhibitors of HCV NS5B polymerase: Discovery of PSI-352938
- (2010) P. Ganapati Reddy et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus
- (2010) Christopher McGuigan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence
- (2010) Kelly P. Burke et al. IMMUNOLOGIC RESEARCH
- Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
- (2010) Eisuke Murakami et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Further Insights into the Roles of GTP and the C Terminus of the Hepatitis C Virus Polymerase in the Initiation of RNA Synthesis
- (2010) Déborah Harrus et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphoramidate ProTides of 2′-C-Methylguanosine as Highly Potent Inhibitors of Hepatitis C Virus. Study of Their in Vitro and in Vivo Properties
- (2010) Christopher McGuigan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a β-d-2′-Deoxy-2′-α-fluoro-2′-β-C-methyluridine Nucleotide Prodrug (PSI-7977) for the Treatment of Hepatitis C Virus
- (2010) Michael J. Sofia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of PSI-353661, a Novel Purine Nucleotide Prodrug for the Treatment of HCV Infection
- (2010) Wonsuk Chang et al. ACS Medicinal Chemistry Letters
- Identification of allosteric inhibitors blocking the hepatitis C virus polymerase NS5B in the RNA synthesis initiation step
- (2009) Stéphane Betzi et al. ANTIVIRAL RESEARCH
- The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4′-azidocytidine (R1479)
- (2009) Christopher McGuigan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The phosphoramidate ProTide approach greatly enhances the activity of β-2′-C-methylguanosine against hepatitis C virus
- (2009) Christopher McGuigan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
- (2009) Youcef Mehellou et al. ChemMedChem
- New Therapies for Hepatitis C Virus Infection
- (2009) Vincent Soriano et al. CLINICAL INFECTIOUS DISEASES
- Cyclic phosphoramidates as prodrugs of 2′-C-methylcytidine
- (2009) Malte Meppen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues
- (2009) Nathaniel A Brown EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trends
- (2009) Phillip A Furman et al. Future Medicinal Chemistry
- Phosphoramidate Prodrugs of 2′-C-Methylcytidine for Therapy of Hepatitis C Virus Infection
- (2009) Cristina Gardelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protease and polymerase inhibitors for the treatment of hepatitis C
- (2009) Tarik Asselah et al. LIVER INTERNATIONAL
- Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected Chimpanzees
- (2008) S. S. Carroll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Selected Replicon Variants with Low-Level In Vitro Resistance to the Hepatitis C Virus NS5B Polymerase Inhibitor PSI-6130 Lack Cross-Resistance with R1479
- (2008) S. Ali et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors
- (2008) M. F. McCown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent progress in the development of selected hepatitis C virus NS3·4A protease and NS5B polymerase inhibitors
- (2008) A KWONG et al. CURRENT OPINION IN PHARMACOLOGY
- R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin
- (2008) Paul J. Pockros et al. HEPATOLOGY
- Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C
- (2008) Stuart K. Roberts et al. HEPATOLOGY
- Existence of hepatitis C virus NS5B variants naturally resistant to non-nucleoside, but not to nucleoside, polymerase inhibitors among untreated patients
- (2008) S. Le Pogam et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 21 LOW LEVEL OF RESISTANCE, LOW VIRAL FITNESS AND ABSENCE OF RESISTANCE MUTATIONS IN BASELINE QUASISPECIES MAY CONTRIBUTE TO HIGH BARRIER TO R1626 RESISTANCE IN VIVO
- (2008) S. Le Pogam et al. JOURNAL OF HEPATOLOGY
- 588 IN VITRO ANTIVIRAL ACTIVITY AND PHARMACOLOGY OF IDX184, A NOVEL AND POTENT INHIBITOR OF HCV REPLICATION
- (2008) E. Cretton-Scott et al. JOURNAL OF HEPATOLOGY
- Prodrugs of Phosphates and Phosphonates
- (2008) Scott J. Hecker et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphate Prodrugs Derived fromN-Acetylglucosamine Have Enhanced Chondroprotective Activity in Explant Cultures and Represent a New Lead in Antiosteoarthritis Drug Discovery
- (2008) Christopher McGuigan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Expert opinion on the treatment of patients with chronic hepatitis C
- (2008) S. Zeuzem et al. JOURNAL OF VIRAL HEPATITIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More